× Important note: Due to the end of funding, these reviews are no longer in living mode. We try to update them on a monthly basis.

meta|Evidence - COVID-19

Living meta-analysis and evidence synthesis of therapies for COVID19  

Member of the meta|Evidence galaxy

tutorial video
En     Fr

Our approach

RSS

       
Treament Trials   auto
deathsclinical improvementdeath or ventilation
0---
0---
3 NaN [NaN; NaN] /10000
0/0 vs. 0/0
346 [-607; 1299] /10000
126/197 vs. 121/200
-
1 / 2 -250 [-837; 337] /10000
2/80 vs. 4/80
--
0 / 2 ---
0---
0 / 1 --
1 -411 [-774; -48] /10000
59/804 vs. 45/393
--456 [-864; -48] /10000
82/804 vs. 58/393
4 111 [-42; 264] /10000
2/180 vs. 0/189
-182 [-730; 366] /10000
112/119 vs. 118/123
-
0 / 1 ---
0---
1 -93 [-316; 130] /10000
86/1180 vs. 86/1046
--117 [-383; 148] /10000
129/1181 vs. 127/1050
0---

Statistically conclusive: statistically significant with a strict control of overall risk of type 1 error (statistically demonstrated), does not take into account the risk of bias; suggested: nominally statistically significant but without a strict control of overall risk of type 1 error; inconclusive: not nominally statistically significant

149
treatments
  718
studies with results
  1743
studies screend
  1629
references

This project is supported by a grant of the French Ministry of Health (Hospital Clinical Research Program, PHRC-N), Université de Lyon (UdL/Idex), and self-funded by Hospices Civils de Lyon, CNRS UMR5558 LBBE University Lyon-1.

     

- About - Our approach - Credits - RSS Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons